Medical Devices: Page 76
-
Permission granted by Vicarious Surgical
Robot startup Vicarious is latest medtech company to cut jobs
Medtech layoffs are continuing, with both startups and industry leaders cutting jobs amid changes brought on by higher interest rates and COVID's impact on supply chains and labor costs.
By Susan Kelly • Feb. 15, 2023 -
Getty Images
Boston Scientific, MDMA call for more transparency and oversight of Medicare Advantage plans
Privately offered Medicare Advantage plans “do not often provide a clear reason for the denial of coverage, and rarely offer any visibility into the evidence and methodology,” trade group MDMA and Boston Scientific said.
By Nick Paul Taylor • Feb. 15, 2023 -
Explore the Trendlineâž”
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Getty Images
Globus’ planned purchase of NuVasive haunted by specter of past spine deals
Past combinations of competing spinal care companies “historically have tended to be messy,” one analyst wrote. Globus’ leaders claim this deal will be different.
By Elise Reuter • Feb. 14, 2023 -
Courtesy of Alcon
Alcon to pay J&J $199M to settle dispute over patents for laser eye surgery device
Alcon is settling the case for far less than the $3.1 billion that J&J’s damages expert argued the company could be owed.
By Nick Paul Taylor • Feb. 14, 2023 -
Baxter, Abbott, Thermo Fisher among medtech firms cutting jobs on supply issues, slide in testing
"What COVID gave to diagnostics companies, COVID taketh away now that the virus is endemic,” said one analyst.
By Susan Kelly • Updated Feb. 13, 2023 -
Courtesy of Dexcom
Dexcom secures Medicare coverage for G7 CGM with device set to launch this week
The decision by the CMS will include coverage for people with Type 1 and Type 2 diabetes who are on intensive insulin therapy.
By Elise Reuter • Feb. 13, 2023 -
Retrieved from Medtronic on September 19, 2022
Medtronic ordered by jury to pay $106.5M to Colibri over TAVR patent infringement
Medtronic says the ruling will have no effect on its TAVR business as the patents expired last year and it vowed to appeal the verdict.
By Nick Paul Taylor • Updated Feb. 14, 2023 -
Alex Wong via Getty Images
OpinionPatent trolls’ destructive lawsuits are curbing US medtech innovation
The Patent and Trademark Office must help stop frivolous litigation that is harming the industry, argues former HHS secretary Tom Price.
By Tom Price • Feb. 10, 2023 -
Thermo Fisher cuts additional 230 jobs in California
The job reductions come amid a downturn in demand for COVID-19 tests.
By Susan Kelly • Updated Feb. 10, 2023 -
Courtesy of Philips
82 more deaths linked to Philips’ recalled devices reported to FDA, bringing total to 346
The rate of death reports per month has risen consistently since Philips began the recall in the summer of 2021.
By Nick Paul Taylor • Feb. 10, 2023 -
Getty Images
Baxter to cut about 3,000 jobs after earnings slump on supply chain woes
The economic slowdown also hurt profit in the period even as the company posted double-digit sales growth.
By Nick Paul Taylor • Feb. 10, 2023 -
Courtesy of Cardiovascular Systems Inc.
Abbott to pay $890M to acquire CSI, gaining atherectomy device
The deal expands Abbott’s vascular device lineup and access to additional products in development.
By Susan Kelly • Feb. 9, 2023 -
Getty Images
Abbott balloon device partner Surmodics cuts jobs after FDA approval delay
The workforce reduction, one of a growing number in the medtech sector, comes after the agency requested more data in a premarket review of the company’s device to treat narrowed leg arteries.
By Susan Kelly • Feb. 9, 2023 -
Getty Images
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Manufacturers that serve other industries are expected to move into medtech through mergers and acquisitions, driving up deal volumes.
By Nick Paul Taylor • Feb. 9, 2023 -
Courtesy of Johnson & Johnson
J&J, Medtronic, Boston Scientific gird for battle over US cardiac ablation market with new trials
Medtech firms are sharing clinical trial results on pulse ablation devices, which they claim are safer and more effective at halting arrhythmias than current methods.
By Elise Reuter • Feb. 8, 2023 -
Getty Images
Trade group pushes back on FDA’s clinical decision support guidance
The Clinical Decision Support Coalition is asking the agency to rescind its guidance and propose new rules that change how software tools are regulated as medical devices.
By Elise Reuter • Feb. 8, 2023 -
nay via Getty Images
Onshoring, easing labor market expected to drive double-digit growth at US medtech CDMOs
The report identifies revised rules on ethylene oxide as a trend to watch, noting that new requirements for sterilization could “[clear] the way for structural changes in the industry.”
By Nick Paul Taylor • Feb. 8, 2023 -
Christopher Furlong via Getty Images
UK health system, under strain, lays out medtech strategy
The state-run National Health Service, now facing a strike by nurses and paramedics, hopes new technologies will help solve some of its long-term challenges to improve patient care.
By Susan Kelly • Feb. 7, 2023 -
Permission granted by Abbott Laboratories
Abbott device approval sets up battle with Medtronic, Nevro for diabetic peripheral neuropathy treatment
Three firms are bringing their devices to a $3 billion to $5 billion market, aiming to relieve a painful side effect of diabetes.
By Elise Reuter • Feb. 6, 2023 -
Getty Images
Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023
Still, the latest round of quarterly results show that hospital staffing and supply chain remain a challenge.
By Nick Paul Taylor • Feb. 6, 2023 -
Ian Waldie via Getty Images
Sensor-loaded, $1 smart glove being tested to reduce stillbirths, maternal deaths
The researchers plan to run clinical trials to show if the device can provide an early warning system for physical impediments to birth.
By Nick Paul Taylor • Feb. 6, 2023 -
Permission granted by Zimmer Biomet
Zimmer Biomet Q4 net loss widens on supply problems; CEO targets acquisitions
The company plans to enter higher-growth markets, even outside of orthopedics, in a bid to increase revenue.
By Elise Reuter • Feb. 3, 2023 -
Courtesy of Invacare
Invacare files for Chapter 11 bankruptcy protection amid supply chain woes
The wheelchair maker said it has reached a restructuring agreement with most of its debt holders and that demand for its products remains strong.
By Susan Kelly • Updated Feb. 3, 2023 -
Permission granted by Becton Dickinson
BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables
The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.
By Susan Kelly • Feb. 2, 2023 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes
Lower diagnostics revenue hurt sales in the three months ended Dec. 31.
By Nick Paul Taylor • Feb. 2, 2023
Previous
